These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2112378

  • 1. In vitro antimicrobial activity of defensins against ocular pathogens.
    Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW.
    Arch Ophthalmol; 1990 Jun; 108(6):861-4. PubMed ID: 2112378
    [Abstract] [Full Text] [Related]

  • 2. Corneal storage medium preservation with defensins.
    Schwab IR, Dries D, Cullor J, Smith W, Mannis M, Reid T, Murphy CJ.
    Cornea; 1992 Sep; 11(5):370-5. PubMed ID: 1424662
    [Abstract] [Full Text] [Related]

  • 3. Bactericidal potency and mechanistic specificity of neutrophil defensins against bovine mastitis pathogens.
    Cullor JS, Wood S, Smith W, Panico L, Selsted ME.
    Vet Microbiol; 1991 Sep; 29(1):49-58. PubMed ID: 1949554
    [Abstract] [Full Text] [Related]

  • 4. Bacterial isolates and antimicrobial susceptibilities in equine bacterial ulcerative keratitis (1993--2004).
    Keller RL, Hendrix DV.
    Equine Vet J; 2005 May; 37(3):207-11. PubMed ID: 15892227
    [Abstract] [Full Text] [Related]

  • 5. In vitro antimicrobial activity of Shiva-11 against ocular pathogens.
    Gunshefski L, Mannis MJ, Cullor JS, Schwab IR, Jaynes J, Smith WL, Mabry E, Murphy CJ.
    Cornea; 1994 May; 13(3):237-42. PubMed ID: 8033574
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, Li JD, Nagura M, Ganz T, Lim DJ.
    BMC Infect Dis; 2004 May 05; 4():12. PubMed ID: 15125783
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of rabbit leukocyte defensins against Treponema pallidum subsp. pallidum.
    Borenstein LA, Selsted ME, Lehrer RI, Miller JN.
    Infect Immun; 1991 Apr 05; 59(4):1359-67. PubMed ID: 2004816
    [Abstract] [Full Text] [Related]

  • 8. In vitro efficacy of an ophthalmic drug combination against corneal pathogens of horses.
    Scotty NC, Brooks DE, Schuman Rose CD.
    Am J Vet Res; 2008 Jan 05; 69(1):101-7. PubMed ID: 18167094
    [Abstract] [Full Text] [Related]

  • 9. Large-scale synthesis and functional elements for the antimicrobial activity of defensins.
    Raj PA, Antonyraj KJ, Karunakaran T.
    Biochem J; 2000 May 01; 347 Pt 3(Pt 3):633-41. PubMed ID: 10769165
    [Abstract] [Full Text] [Related]

  • 10. In vitro antimicrobial susceptibility of equine clinical isolates from France, 2006-2016.
    Duchesne R, Castagnet S, Maillard K, Petry S, Cattoir V, Giard JC, Leon A.
    J Glob Antimicrob Resist; 2019 Dec 01; 19():144-153. PubMed ID: 30880244
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.
    Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A.
    Invest Ophthalmol Vis Sci; 2008 Aug 01; 49(8):3402-8. PubMed ID: 18408193
    [Abstract] [Full Text] [Related]

  • 12. The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears.
    McDermott AM, Rich D, Cullor J, Mannis MJ, Smith W, Reid T, Murphy CJ.
    Br J Ophthalmol; 2006 May 01; 90(5):609-11. PubMed ID: 16622092
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of temperature on the antimicrobial activity of Optisol-GS.
    Kapur R, Tu EY, Pendland SL, Fiscella R, Sugar J.
    Cornea; 2006 Apr 01; 25(3):319-24. PubMed ID: 16633033
    [Abstract] [Full Text] [Related]

  • 17. Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens.
    Payne JE, Dubois AV, Ingram RJ, Weldon S, Taggart CC, Elborn JS, Tunney MM.
    Int J Antimicrob Agents; 2017 Sep 01; 50(3):427-435. PubMed ID: 28666755
    [Abstract] [Full Text] [Related]

  • 18. [In vitro antimicrobial activity of defensins from rabbit neutrophils against Pseudomonas aeruginosa and its multiple-drug-resistance strains].
    Zhao WY, Dong BR, Zhou Y.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan 01; 36(1):83-5. PubMed ID: 15702789
    [Abstract] [Full Text] [Related]

  • 19. Microbicidal effects of α- and θ-defensins against antibiotic-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Tai KP, Kamdar K, Yamaki J, Le VV, Tran D, Tran P, Selsted ME, Ouellette AJ, Wong-Beringer A.
    Innate Immun; 2015 Jan 01; 21(1):17-29. PubMed ID: 24345876
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA, Gerding DN, Peterson LR.
    Am J Med; 1987 Apr 27; 82(4A):44-54. PubMed ID: 3107380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.